Cargando…
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
BACKGROUND: EGFR is an important signal involved in tumor growth that can induce tumor metastasis and drug resistance. Exploring targets for effective EGFR regulation is an important topic in current research and drug development. Inhibiting EGFR can effectively inhibit the progression and lymph nod...
Autores principales: | Huang, Zixian, Rui, Xi, Yi, Chen, Chen, Yongju, Chen, Rui, Liang, Yancan, Wang, Yan, Yao, Weicheng, Xu, Xiaoding, Huang, Zhiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007849/ https://www.ncbi.nlm.nih.gov/pubmed/36899380 http://dx.doi.org/10.1186/s13046-023-02618-z |
Ejemplares similares
-
Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023) -
Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2019) -
Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2020) -
RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma
por: Rui, Xi, et al.
Publicado: (2022) -
GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2α and activating the ER-stress response
por: Zhang, Qianyu, et al.
Publicado: (2022)